# Humacyte, Inc.: Form D filings

Humacyte, Inc., a biotechnology company in Durham, NC, filed 7 Form D notices with the SEC between 2009 and 2018. The latest, on June 26, 2018, reports $150 million sold of a $150 million offering to 1 investor.

Find out what Humacyte, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Humacyte%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Humacyte%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fhumacyte-inc-1385943)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Humacyte%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Humacyte%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fhumacyte-inc-1385943)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2525 E. NC HIGHWAY 54, Durham, NC, 27713
- Phone: (919) 313-9633
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1385943

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 26, 2018 | New notice | $150,000,000 | $150,000,000 | $0 | 1 | Jun 25, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000138594318000004/0001385943-18-000004-index.htm) |
| Mar 9, 2018 | New notice | $75,000,000 | $74,999,980 | $20 | 29 | Feb 23, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000138594318000003/0001385943-18-000003-index.htm) |
| Jan 20, 2015 | Amendment | $73,762,373 | $49,762,373 | $24,000,000 | 6 | Oct 1, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000138594315000003/0001385943-15-000003-index.htm) |
| Jan 21, 2014 | Amendment | $49,100,000 | $37,262,373 | $11,837,627 | 6 | Oct 1, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000138594314000002/0001385943-14-000002-index.htm) |
| Apr 9, 2012 | Amendment | $27,000,000 | $22,000,000 | $5,000,000 | 2 | Oct 1, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000138594312000001/0001385943-12-000001-index.htm) |
| Sep 2, 2010 | Amendment | $12,000,000 | $12,000,000 | $0 | 1 | Oct 1, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000138594310000002/0001385943-10-000002-index.htm) |
| Nov 23, 2009 | Amendment | $7,000,000 | $7,000,000 | $0 | 1 | Oct 1, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385943/000133618509000004/0001336185-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jeffrey H. Lawson | Executive Officer |  |
| Paul A. Boyer | Executive Officer |  |
| Theodore D. Lithgow | Executive Officer |  |
| Robert S. Langer | Director |  |
| Dale A. Sander | Director |  |
| Robert Anderson | Director |  |
| Carrie S. Cox | Executive Officer, Director |  |
| William H. Tente | Executive Officer |  |
| Brady W. Dougan | Director |  |
| Kathleen A. Sebelius | Director |  |
| Laura E. Niklason | Director |  |
| Max N. Wallace | Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Jun 25, 2018](https://specstream.ai/data/form-d/week/2018-06-25) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Humacyte, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).